<DOC>
	<DOC>NCT00326326</DOC>
	<brief_summary>To assess the effect of CP-778,875 on HDL-C cholesterol in adult subjects with dyslipidemia and type 2 diabetes</brief_summary>
	<brief_title>Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>HDLC &lt; or = 45 mg/dL for men and &lt; or = 55 mg/dL for women Triglycerides between 150500 mg/dL Fasting Plasma Glucose 140240 mg/dL Known cardiovascular, carotid, or peripheral vascular disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>